nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS2—stomach cancer	0.299	0.529	CbGaD
Bismuth Subsalicylate—ALB—stomach cancer	0.267	0.471	CbGaD
Bismuth Subsalicylate—ALB—Irinotecan—stomach cancer	0.0405	0.402	CbGbCtD
Bismuth Subsalicylate—ALB—Fluorouracil—stomach cancer	0.0389	0.386	CbGbCtD
Bismuth Subsalicylate—TF—bile—stomach cancer	0.0259	0.282	CbGeAlD
Bismuth Subsalicylate—ALB—Methotrexate—stomach cancer	0.0214	0.213	CbGbCtD
Bismuth Subsalicylate—TF—blood vessel—stomach cancer	0.00763	0.0831	CbGeAlD
Bismuth Subsalicylate—TF—gall bladder—stomach cancer	0.00718	0.0782	CbGeAlD
Bismuth Subsalicylate—TF—hematopoietic system—stomach cancer	0.00406	0.0442	CbGeAlD
Bismuth Subsalicylate—ALB—gall bladder—stomach cancer	0.00373	0.0407	CbGeAlD
Bismuth Subsalicylate—TF—epithelium—stomach cancer	0.00371	0.0404	CbGeAlD
Bismuth Subsalicylate—TF—pancreas—stomach cancer	0.00331	0.036	CbGeAlD
Bismuth Subsalicylate—TF—lymphoid tissue—stomach cancer	0.00286	0.0312	CbGeAlD
Bismuth Subsalicylate—TF—digestive system—stomach cancer	0.00283	0.0308	CbGeAlD
Bismuth Subsalicylate—TF—bone marrow—stomach cancer	0.0026	0.0284	CbGeAlD
Bismuth Subsalicylate—TF—endocrine gland—stomach cancer	0.00233	0.0254	CbGeAlD
Bismuth Subsalicylate—PTGS1—blood vessel—stomach cancer	0.00226	0.0246	CbGeAlD
Bismuth Subsalicylate—PTGS2—blood vessel—stomach cancer	0.00216	0.0235	CbGeAlD
Bismuth Subsalicylate—TF—liver—stomach cancer	0.0021	0.0229	CbGeAlD
Bismuth Subsalicylate—PTGS2—gall bladder—stomach cancer	0.00203	0.0222	CbGeAlD
Bismuth Subsalicylate—TF—lymph node—stomach cancer	0.00161	0.0176	CbGeAlD
Bismuth Subsalicylate—PTGS1—hematopoietic system—stomach cancer	0.0012	0.0131	CbGeAlD
Bismuth Subsalicylate—PTGS2—hematopoietic system—stomach cancer	0.00115	0.0125	CbGeAlD
Bismuth Subsalicylate—PTGS1—epithelium—stomach cancer	0.0011	0.012	CbGeAlD
Bismuth Subsalicylate—ALB—liver—stomach cancer	0.0011	0.0119	CbGeAlD
Bismuth Subsalicylate—PTGS1—smooth muscle tissue—stomach cancer	0.00106	0.0116	CbGeAlD
Bismuth Subsalicylate—PTGS2—epithelium—stomach cancer	0.00105	0.0115	CbGeAlD
Bismuth Subsalicylate—PTGS2—smooth muscle tissue—stomach cancer	0.00101	0.011	CbGeAlD
Bismuth Subsalicylate—PTGS2—pancreas—stomach cancer	0.000937	0.0102	CbGeAlD
Bismuth Subsalicylate—Body temperature increased—Floxuridine—stomach cancer	0.000915	0.00671	CcSEcCtD
Bismuth Subsalicylate—Oedema—Mitomycin—stomach cancer	0.000908	0.00666	CcSEcCtD
Bismuth Subsalicylate—Gastric ulcer—Epirubicin—stomach cancer	0.000887	0.0065	CcSEcCtD
Bismuth Subsalicylate—Venous thrombosis—Doxorubicin—stomach cancer	0.000884	0.00648	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Docetaxel—stomach cancer	0.000876	0.00642	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Mitomycin—stomach cancer	0.000866	0.00635	CcSEcCtD
Bismuth Subsalicylate—ALB—lymph node—stomach cancer	0.00084	0.00914	CbGeAlD
Bismuth Subsalicylate—PTGS1—digestive system—stomach cancer	0.000838	0.00912	CbGeAlD
Bismuth Subsalicylate—Gastric ulcer—Doxorubicin—stomach cancer	0.000821	0.00602	CcSEcCtD
Bismuth Subsalicylate—PTGS2—lymphoid tissue—stomach cancer	0.000811	0.00883	CbGeAlD
Bismuth Subsalicylate—Somnolence—Mitomycin—stomach cancer	0.000807	0.00592	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Irinotecan—stomach cancer	0.000806	0.00591	CcSEcCtD
Bismuth Subsalicylate—Hearing impaired—Docetaxel—stomach cancer	0.000803	0.00589	CcSEcCtD
Bismuth Subsalicylate—PTGS2—digestive system—stomach cancer	0.000801	0.00872	CbGeAlD
Bismuth Subsalicylate—Burning sensation—Methotrexate—stomach cancer	0.000793	0.00581	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Floxuridine—stomach cancer	0.000792	0.00581	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Mitomycin—stomach cancer	0.00079	0.00579	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Fluorouracil—stomach cancer	0.000784	0.00575	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Methotrexate—stomach cancer	0.000778	0.00571	CcSEcCtD
Bismuth Subsalicylate—Hearing impaired—Capecitabine—stomach cancer	0.000777	0.0057	CcSEcCtD
Bismuth Subsalicylate—Pain—Mitomycin—stomach cancer	0.000777	0.00569	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Mitomycin—stomach cancer	0.000748	0.00549	CcSEcCtD
Bismuth Subsalicylate—Burning sensation—Epirubicin—stomach cancer	0.000742	0.00544	CcSEcCtD
Bismuth Subsalicylate—PTGS2—bone marrow—stomach cancer	0.000738	0.00804	CbGeAlD
Bismuth Subsalicylate—Vomiting—Floxuridine—stomach cancer	0.000736	0.0054	CcSEcCtD
Bismuth Subsalicylate—Rash—Floxuridine—stomach cancer	0.00073	0.00535	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Docetaxel—stomach cancer	0.00073	0.00535	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Floxuridine—stomach cancer	0.000729	0.00535	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Epirubicin—stomach cancer	0.000728	0.00534	CcSEcCtD
Bismuth Subsalicylate—Headache—Floxuridine—stomach cancer	0.000725	0.00532	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Mitomycin—stomach cancer	0.000718	0.00526	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Capecitabine—stomach cancer	0.000706	0.00518	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Docetaxel—stomach cancer	0.000698	0.00512	CcSEcCtD
Bismuth Subsalicylate—PTGS1—endocrine gland—stomach cancer	0.000692	0.00754	CbGeAlD
Bismuth Subsalicylate—Nausea—Floxuridine—stomach cancer	0.000688	0.00504	CcSEcCtD
Bismuth Subsalicylate—Burning sensation—Doxorubicin—stomach cancer	0.000687	0.00503	CcSEcCtD
Bismuth Subsalicylate—Lightheadedness—Docetaxel—stomach cancer	0.000684	0.00501	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Capecitabine—stomach cancer	0.000676	0.00496	CcSEcCtD
Bismuth Subsalicylate—Lung disorder—Doxorubicin—stomach cancer	0.000674	0.00494	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Capecitabine—stomach cancer	0.000669	0.0049	CcSEcCtD
Bismuth Subsalicylate—PTGS2—endocrine gland—stomach cancer	0.000662	0.00721	CbGeAlD
Bismuth Subsalicylate—Phlebitis—Docetaxel—stomach cancer	0.000644	0.00472	CcSEcCtD
Bismuth Subsalicylate—Stinging—Epirubicin—stomach cancer	0.000636	0.00466	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Methotrexate—stomach cancer	0.000631	0.00463	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Capecitabine—stomach cancer	0.000623	0.00457	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Mitomycin—stomach cancer	0.000621	0.00456	CcSEcCtD
Bismuth Subsalicylate—Deafness—Docetaxel—stomach cancer	0.00062	0.00455	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Mitomycin—stomach cancer	0.000601	0.0044	CcSEcCtD
Bismuth Subsalicylate—Deafness—Capecitabine—stomach cancer	0.0006	0.0044	CcSEcCtD
Bismuth Subsalicylate—PTGS2—liver—stomach cancer	0.000596	0.0065	CbGeAlD
Bismuth Subsalicylate—Extravasation—Epirubicin—stomach cancer	0.000591	0.00433	CcSEcCtD
Bismuth Subsalicylate—Stinging—Doxorubicin—stomach cancer	0.000589	0.00432	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Mitomycin—stomach cancer	0.000577	0.00423	CcSEcCtD
Bismuth Subsalicylate—Rash—Mitomycin—stomach cancer	0.000573	0.0042	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Mitomycin—stomach cancer	0.000572	0.00419	CcSEcCtD
Bismuth Subsalicylate—Headache—Mitomycin—stomach cancer	0.000569	0.00417	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Docetaxel—stomach cancer	0.000566	0.00415	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Fluorouracil—stomach cancer	0.000559	0.0041	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Docetaxel—stomach cancer	0.000557	0.00408	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Capecitabine—stomach cancer	0.000548	0.00402	CcSEcCtD
Bismuth Subsalicylate—Extravasation—Doxorubicin—stomach cancer	0.000547	0.00401	CcSEcCtD
Bismuth Subsalicylate—Nausea—Mitomycin—stomach cancer	0.000539	0.00396	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Capecitabine—stomach cancer	0.000539	0.00395	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Methotrexate—stomach cancer	0.000526	0.00386	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Docetaxel—stomach cancer	0.000507	0.00371	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Methotrexate—stomach cancer	0.000498	0.00365	CcSEcCtD
Bismuth Subsalicylate—Skin exfoliation—Epirubicin—stomach cancer	0.000492	0.00361	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Capecitabine—stomach cancer	0.000491	0.0036	CcSEcCtD
Bismuth Subsalicylate—PTGS1—lymph node—stomach cancer	0.000478	0.00521	CbGeAlD
Bismuth Subsalicylate—Oesophagitis—Epirubicin—stomach cancer	0.000471	0.00345	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Epirubicin—stomach cancer	0.000466	0.00342	CcSEcCtD
Bismuth Subsalicylate—Asthma—Capecitabine—stomach cancer	0.000464	0.0034	CcSEcCtD
Bismuth Subsalicylate—Erythema—Fluorouracil—stomach cancer	0.000463	0.00339	CcSEcCtD
Bismuth Subsalicylate—PTGS2—lymph node—stomach cancer	0.000457	0.00498	CbGeAlD
Bismuth Subsalicylate—Skin exfoliation—Doxorubicin—stomach cancer	0.000455	0.00334	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Capecitabine—stomach cancer	0.000445	0.00326	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Docetaxel—stomach cancer	0.000436	0.0032	CcSEcCtD
Bismuth Subsalicylate—Oesophagitis—Doxorubicin—stomach cancer	0.000436	0.0032	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Epirubicin—stomach cancer	0.000434	0.00318	CcSEcCtD
Bismuth Subsalicylate—Ecchymosis—Doxorubicin—stomach cancer	0.000431	0.00316	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Capecitabine—stomach cancer	0.000422	0.0031	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Methotrexate—stomach cancer	0.000408	0.00299	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Docetaxel—stomach cancer	0.000403	0.00296	CcSEcCtD
Bismuth Subsalicylate—Phlebitis—Doxorubicin—stomach cancer	0.000402	0.00295	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Irinotecan—stomach cancer	0.000398	0.00292	CcSEcCtD
Bismuth Subsalicylate—Oedema—Irinotecan—stomach cancer	0.000394	0.00289	CcSEcCtD
Bismuth Subsalicylate—Infection—Irinotecan—stomach cancer	0.000392	0.00287	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Capecitabine—stomach cancer	0.00039	0.00286	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Docetaxel—stomach cancer	0.000384	0.00281	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Epirubicin—stomach cancer	0.000382	0.0028	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Fluorouracil—stomach cancer	0.000381	0.00279	CcSEcCtD
Bismuth Subsalicylate—Oedema—Fluorouracil—stomach cancer	0.000378	0.00277	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Irinotecan—stomach cancer	0.000376	0.00276	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Epirubicin—stomach cancer	0.000376	0.00275	CcSEcCtD
Bismuth Subsalicylate—Infection—Fluorouracil—stomach cancer	0.000375	0.00275	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Capecitabine—stomach cancer	0.000372	0.00272	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Docetaxel—stomach cancer	0.000363	0.00266	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Fluorouracil—stomach cancer	0.00036	0.00264	CcSEcCtD
Bismuth Subsalicylate—Lethargy—Doxorubicin—stomach cancer	0.000353	0.00259	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Capecitabine—stomach cancer	0.000351	0.00258	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Irinotecan—stomach cancer	0.000351	0.00257	CcSEcCtD
Bismuth Subsalicylate—Hyponatraemia—Doxorubicin—stomach cancer	0.000348	0.00255	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Irinotecan—stomach cancer	0.000347	0.00255	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Capecitabine—stomach cancer	0.000346	0.00254	CcSEcCtD
Bismuth Subsalicylate—Asthma—Methotrexate—stomach cancer	0.000346	0.00253	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Irinotecan—stomach cancer	0.000343	0.00251	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Epirubicin—stomach cancer	0.000342	0.00251	CcSEcCtD
Bismuth Subsalicylate—Pain—Irinotecan—stomach cancer	0.000337	0.00247	CcSEcCtD
Bismuth Subsalicylate—Constipation—Irinotecan—stomach cancer	0.000337	0.00247	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Fluorouracil—stomach cancer	0.000336	0.00246	CcSEcCtD
Bismuth Subsalicylate—Erythema—Docetaxel—stomach cancer	0.000334	0.00245	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Fluorouracil—stomach cancer	0.000333	0.00244	CcSEcCtD
Bismuth Subsalicylate—Abdominal discomfort—Methotrexate—stomach cancer	0.000331	0.00243	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Fluorouracil—stomach cancer	0.000328	0.00241	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Docetaxel—stomach cancer	0.000327	0.0024	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Irinotecan—stomach cancer	0.000325	0.00238	CcSEcCtD
Bismuth Subsalicylate—Erythema—Capecitabine—stomach cancer	0.000323	0.00237	CcSEcCtD
Bismuth Subsalicylate—Asthma—Epirubicin—stomach cancer	0.000323	0.00237	CcSEcCtD
Bismuth Subsalicylate—Pain—Fluorouracil—stomach cancer	0.000323	0.00237	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Capecitabine—stomach cancer	0.000317	0.00232	CcSEcCtD
Bismuth Subsalicylate—Abdominal pain upper—Doxorubicin—stomach cancer	0.000316	0.00232	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Irinotecan—stomach cancer	0.000312	0.00229	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Fluorouracil—stomach cancer	0.000311	0.00228	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Methotrexate—stomach cancer	0.000308	0.00226	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Fluorouracil—stomach cancer	0.0003	0.0022	CcSEcCtD
Bismuth Subsalicylate—Asthma—Doxorubicin—stomach cancer	0.000299	0.00219	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Fluorouracil—stomach cancer	0.000299	0.00219	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Epirubicin—stomach cancer	0.000294	0.00216	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Methotrexate—stomach cancer	0.000291	0.00213	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Epirubicin—stomach cancer	0.000288	0.00211	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Methotrexate—stomach cancer	0.000277	0.00203	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Docetaxel—stomach cancer	0.000275	0.00202	CcSEcCtD
Bismuth Subsalicylate—Oedema—Docetaxel—stomach cancer	0.000273	0.002	CcSEcCtD
Bismuth Subsalicylate—Weight increased—Doxorubicin—stomach cancer	0.000272	0.002	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Epirubicin—stomach cancer	0.000272	0.00199	CcSEcCtD
Bismuth Subsalicylate—Infection—Docetaxel—stomach cancer	0.000271	0.00199	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Irinotecan—stomach cancer	0.00027	0.00198	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Fluorouracil—stomach cancer	0.000267	0.00196	CcSEcCtD
Bismuth Subsalicylate—Drowsiness—Doxorubicin—stomach cancer	0.000267	0.00196	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Capecitabine—stomach cancer	0.000266	0.00195	CcSEcCtD
Bismuth Subsalicylate—Oedema—Capecitabine—stomach cancer	0.000264	0.00194	CcSEcCtD
Bismuth Subsalicylate—Infection—Capecitabine—stomach cancer	0.000262	0.00192	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Methotrexate—stomach cancer	0.000262	0.00192	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Irinotecan—stomach cancer	0.000261	0.00191	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Docetaxel—stomach cancer	0.00026	0.00191	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Epirubicin—stomach cancer	0.000259	0.0019	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Fluorouracil—stomach cancer	0.000258	0.00189	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Methotrexate—stomach cancer	0.000258	0.00189	CcSEcCtD
Bismuth Subsalicylate—Epistaxis—Doxorubicin—stomach cancer	0.000252	0.00184	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Capecitabine—stomach cancer	0.000252	0.00184	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Irinotecan—stomach cancer	0.000251	0.00184	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Fluorouracil—stomach cancer	0.00025	0.00183	CcSEcCtD
Bismuth Subsalicylate—Rash—Irinotecan—stomach cancer	0.000249	0.00182	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Irinotecan—stomach cancer	0.000248	0.00182	CcSEcCtD
Bismuth Subsalicylate—Headache—Irinotecan—stomach cancer	0.000247	0.00181	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Epirubicin—stomach cancer	0.000245	0.00179	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Docetaxel—stomach cancer	0.000242	0.00178	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Epirubicin—stomach cancer	0.000241	0.00177	CcSEcCtD
Bismuth Subsalicylate—Erythema—Methotrexate—stomach cancer	0.000241	0.00177	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Fluorouracil—stomach cancer	0.00024	0.00176	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Docetaxel—stomach cancer	0.00024	0.00176	CcSEcCtD
Bismuth Subsalicylate—Hepatitis—Doxorubicin—stomach cancer	0.00024	0.00176	CcSEcCtD
Bismuth Subsalicylate—Rash—Fluorouracil—stomach cancer	0.000238	0.00175	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Fluorouracil—stomach cancer	0.000238	0.00174	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Docetaxel—stomach cancer	0.000237	0.00174	CcSEcCtD
Bismuth Subsalicylate—Headache—Fluorouracil—stomach cancer	0.000237	0.00174	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Methotrexate—stomach cancer	0.000236	0.00173	CcSEcCtD
Bismuth Subsalicylate—Nausea—Irinotecan—stomach cancer	0.000234	0.00172	CcSEcCtD
Bismuth Subsalicylate—Pain—Docetaxel—stomach cancer	0.000233	0.00171	CcSEcCtD
Bismuth Subsalicylate—Constipation—Docetaxel—stomach cancer	0.000233	0.00171	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Capecitabine—stomach cancer	0.000232	0.0017	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Capecitabine—stomach cancer	0.000229	0.00168	CcSEcCtD
Bismuth Subsalicylate—Erythema multiforme—Doxorubicin—stomach cancer	0.000226	0.00166	CcSEcCtD
Bismuth Subsalicylate—Constipation—Capecitabine—stomach cancer	0.000226	0.00166	CcSEcCtD
Bismuth Subsalicylate—Pain—Capecitabine—stomach cancer	0.000226	0.00166	CcSEcCtD
Bismuth Subsalicylate—Erythema—Epirubicin—stomach cancer	0.000225	0.00165	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Docetaxel—stomach cancer	0.000225	0.00165	CcSEcCtD
Bismuth Subsalicylate—Nausea—Fluorouracil—stomach cancer	0.000224	0.00165	CcSEcCtD
Bismuth Subsalicylate—Tinnitus—Doxorubicin—stomach cancer	0.000223	0.00164	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Epirubicin—stomach cancer	0.000221	0.00162	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Capecitabine—stomach cancer	0.000218	0.00159	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Docetaxel—stomach cancer	0.000216	0.00158	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Capecitabine—stomach cancer	0.00021	0.00154	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Capecitabine—stomach cancer	0.000209	0.00153	CcSEcCtD
Bismuth Subsalicylate—Erythema—Doxorubicin—stomach cancer	0.000209	0.00153	CcSEcCtD
Bismuth Subsalicylate—Dysgeusia—Doxorubicin—stomach cancer	0.000204	0.0015	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Methotrexate—stomach cancer	0.000198	0.00145	CcSEcCtD
Bismuth Subsalicylate—Infection—Methotrexate—stomach cancer	0.000195	0.00143	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Docetaxel—stomach cancer	0.000193	0.00141	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Methotrexate—stomach cancer	0.000187	0.00137	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Capecitabine—stomach cancer	0.000187	0.00137	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Docetaxel—stomach cancer	0.000187	0.00137	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Epirubicin—stomach cancer	0.000185	0.00136	CcSEcCtD
Bismuth Subsalicylate—Oedema—Epirubicin—stomach cancer	0.000184	0.00135	CcSEcCtD
Bismuth Subsalicylate—Infection—Epirubicin—stomach cancer	0.000183	0.00134	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Capecitabine—stomach cancer	0.000181	0.00132	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Docetaxel—stomach cancer	0.00018	0.00132	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Epirubicin—stomach cancer	0.000175	0.00129	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Methotrexate—stomach cancer	0.000175	0.00128	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Capecitabine—stomach cancer	0.000175	0.00128	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Docetaxel—stomach cancer	0.000173	0.00127	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Methotrexate—stomach cancer	0.000173	0.00127	CcSEcCtD
Bismuth Subsalicylate—Rash—Docetaxel—stomach cancer	0.000172	0.00126	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Docetaxel—stomach cancer	0.000172	0.00126	CcSEcCtD
Bismuth Subsalicylate—Confusional state—Doxorubicin—stomach cancer	0.000172	0.00126	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Methotrexate—stomach cancer	0.000171	0.00125	CcSEcCtD
Bismuth Subsalicylate—Headache—Docetaxel—stomach cancer	0.000171	0.00125	CcSEcCtD
Bismuth Subsalicylate—Oedema—Doxorubicin—stomach cancer	0.00017	0.00125	CcSEcCtD
Bismuth Subsalicylate—Infection—Doxorubicin—stomach cancer	0.000169	0.00124	CcSEcCtD
Bismuth Subsalicylate—Pain—Methotrexate—stomach cancer	0.000168	0.00123	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Capecitabine—stomach cancer	0.000168	0.00123	CcSEcCtD
Bismuth Subsalicylate—Rash—Capecitabine—stomach cancer	0.000166	0.00122	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Capecitabine—stomach cancer	0.000166	0.00122	CcSEcCtD
Bismuth Subsalicylate—Headache—Capecitabine—stomach cancer	0.000165	0.00121	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Epirubicin—stomach cancer	0.000164	0.0012	CcSEcCtD
Bismuth Subsalicylate—Anorexia—Doxorubicin—stomach cancer	0.000162	0.00119	CcSEcCtD
Bismuth Subsalicylate—Nausea—Docetaxel—stomach cancer	0.000162	0.00119	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Methotrexate—stomach cancer	0.000162	0.00119	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Epirubicin—stomach cancer	0.000162	0.00119	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Epirubicin—stomach cancer	0.00016	0.00117	CcSEcCtD
Bismuth Subsalicylate—Constipation—Epirubicin—stomach cancer	0.000157	0.00115	CcSEcCtD
Bismuth Subsalicylate—Pain—Epirubicin—stomach cancer	0.000157	0.00115	CcSEcCtD
Bismuth Subsalicylate—Nausea—Capecitabine—stomach cancer	0.000157	0.00115	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Methotrexate—stomach cancer	0.000156	0.00114	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Methotrexate—stomach cancer	0.000155	0.00114	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Epirubicin—stomach cancer	0.000152	0.00111	CcSEcCtD
Bismuth Subsalicylate—Somnolence—Doxorubicin—stomach cancer	0.000151	0.00111	CcSEcCtD
Bismuth Subsalicylate—Dyspepsia—Doxorubicin—stomach cancer	0.00015	0.0011	CcSEcCtD
Bismuth Subsalicylate—Decreased appetite—Doxorubicin—stomach cancer	0.000148	0.00108	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Epirubicin—stomach cancer	0.000146	0.00107	CcSEcCtD
Bismuth Subsalicylate—Constipation—Doxorubicin—stomach cancer	0.000146	0.00107	CcSEcCtD
Bismuth Subsalicylate—Pain—Doxorubicin—stomach cancer	0.000146	0.00107	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Epirubicin—stomach cancer	0.000145	0.00107	CcSEcCtD
Bismuth Subsalicylate—Feeling abnormal—Doxorubicin—stomach cancer	0.00014	0.00103	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Methotrexate—stomach cancer	0.000139	0.00102	CcSEcCtD
Bismuth Subsalicylate—Urticaria—Doxorubicin—stomach cancer	0.000135	0.000991	CcSEcCtD
Bismuth Subsalicylate—Body temperature increased—Doxorubicin—stomach cancer	0.000135	0.000986	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Methotrexate—stomach cancer	0.000134	0.000986	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Epirubicin—stomach cancer	0.00013	0.000954	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Methotrexate—stomach cancer	0.00013	0.000953	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Epirubicin—stomach cancer	0.000126	0.000923	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Methotrexate—stomach cancer	0.000125	0.000916	CcSEcCtD
Bismuth Subsalicylate—Rash—Methotrexate—stomach cancer	0.000124	0.000908	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Methotrexate—stomach cancer	0.000124	0.000908	CcSEcCtD
Bismuth Subsalicylate—Headache—Methotrexate—stomach cancer	0.000123	0.000903	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Epirubicin—stomach cancer	0.000122	0.000892	CcSEcCtD
Bismuth Subsalicylate—Pruritus—Doxorubicin—stomach cancer	0.00012	0.000883	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Epirubicin—stomach cancer	0.000117	0.000857	CcSEcCtD
Bismuth Subsalicylate—Nausea—Methotrexate—stomach cancer	0.000117	0.000856	CcSEcCtD
Bismuth Subsalicylate—Diarrhoea—Doxorubicin—stomach cancer	0.000116	0.000854	CcSEcCtD
Bismuth Subsalicylate—Rash—Epirubicin—stomach cancer	0.000116	0.00085	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Epirubicin—stomach cancer	0.000116	0.000849	CcSEcCtD
Bismuth Subsalicylate—Headache—Epirubicin—stomach cancer	0.000115	0.000845	CcSEcCtD
Bismuth Subsalicylate—Dizziness—Doxorubicin—stomach cancer	0.000113	0.000825	CcSEcCtD
Bismuth Subsalicylate—Nausea—Epirubicin—stomach cancer	0.000109	0.000801	CcSEcCtD
Bismuth Subsalicylate—Vomiting—Doxorubicin—stomach cancer	0.000108	0.000793	CcSEcCtD
Bismuth Subsalicylate—Rash—Doxorubicin—stomach cancer	0.000107	0.000787	CcSEcCtD
Bismuth Subsalicylate—Dermatitis—Doxorubicin—stomach cancer	0.000107	0.000786	CcSEcCtD
Bismuth Subsalicylate—Headache—Doxorubicin—stomach cancer	0.000107	0.000782	CcSEcCtD
Bismuth Subsalicylate—Nausea—Doxorubicin—stomach cancer	0.000101	0.000741	CcSEcCtD
Bismuth Subsalicylate—PTGS1—Metabolism—PLIN2—stomach cancer	5.32e-05	0.000508	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	5.32e-05	0.000507	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PGLS—stomach cancer	5.29e-05	0.000504	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—BLVRB—stomach cancer	5.29e-05	0.000504	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—stomach cancer	5.28e-05	0.000504	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TP53—stomach cancer	5.26e-05	0.000501	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CA2—stomach cancer	5.18e-05	0.000494	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—IDH3B—stomach cancer	5.16e-05	0.000492	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SUCLG1—stomach cancer	5.16e-05	0.000492	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PGAM1—stomach cancer	5.05e-05	0.000481	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NT5E—stomach cancer	5.05e-05	0.000481	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPAP2A—stomach cancer	5.04e-05	0.000481	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PPIA—stomach cancer	5.03e-05	0.00048	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—HRAS—stomach cancer	5.03e-05	0.00048	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TP53—stomach cancer	4.89e-05	0.000466	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	4.85e-05	0.000462	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SERPINA1—stomach cancer	4.84e-05	0.000462	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALDH7A1—stomach cancer	4.82e-05	0.000459	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PLCE1—stomach cancer	4.82e-05	0.000459	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NDUFV1—stomach cancer	4.8e-05	0.000458	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NDUFS1—stomach cancer	4.8e-05	0.000458	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PGAM1—stomach cancer	4.78e-05	0.000456	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—HRAS—stomach cancer	4.76e-05	0.000454	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MAPK3—stomach cancer	4.75e-05	0.000453	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	4.69e-05	0.000447	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MYC—stomach cancer	4.62e-05	0.000441	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—UMPS—stomach cancer	4.62e-05	0.00044	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—WIF1—stomach cancer	4.56e-05	0.000435	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MAPK1—stomach cancer	4.52e-05	0.000431	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—EGFR—stomach cancer	4.52e-05	0.000431	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—APOA1—stomach cancer	4.51e-05	0.00043	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NDUFA2—stomach cancer	4.5e-05	0.000429	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CKB—stomach cancer	4.5e-05	0.000429	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CA1—stomach cancer	4.5e-05	0.000429	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—FBP1—stomach cancer	4.5e-05	0.000429	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL6—stomach cancer	4.47e-05	0.000427	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	4.44e-05	0.000423	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—TNF—stomach cancer	4.4e-05	0.00042	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL6—stomach cancer	4.39e-05	0.000419	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SPARC—stomach cancer	4.38e-05	0.000418	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—F2R—stomach cancer	4.38e-05	0.000418	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TNF—stomach cancer	4.3e-05	0.00041	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PRKCB—stomach cancer	4.3e-05	0.00041	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PDHA1—stomach cancer	4.29e-05	0.000409	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ECHS1—stomach cancer	4.29e-05	0.000409	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RPL13—stomach cancer	4.29e-05	0.000409	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RPL18—stomach cancer	4.29e-05	0.000409	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—IRF1—stomach cancer	4.29e-05	0.000409	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PGLS—stomach cancer	4.28e-05	0.000408	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—BLVRB—stomach cancer	4.28e-05	0.000408	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PLIN2—stomach cancer	4.23e-05	0.000403	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CA2—stomach cancer	4.11e-05	0.000392	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	4.11e-05	0.000392	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPAP2A—stomach cancer	4.08e-05	0.000389	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RNF43—stomach cancer	4.07e-05	0.000388	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—FADS1—stomach cancer	4.04e-05	0.000385	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—TYMP—stomach cancer	4.04e-05	0.000385	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NT5E—stomach cancer	4.01e-05	0.000382	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PGAM1—stomach cancer	4.01e-05	0.000382	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RPS21—stomach cancer	4e-05	0.000382	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RPS15—stomach cancer	4e-05	0.000382	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	3.92e-05	0.000374	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	3.92e-05	0.000374	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	3.91e-05	0.000373	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALDH7A1—stomach cancer	3.82e-05	0.000365	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PLCE1—stomach cancer	3.82e-05	0.000365	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TP53—stomach cancer	3.8e-05	0.000362	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	3.79e-05	0.000362	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SREBF2—stomach cancer	3.78e-05	0.00036	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—RORA—stomach cancer	3.73e-05	0.000356	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CD44—stomach cancer	3.73e-05	0.000355	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	3.7e-05	0.000353	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—UMPS—stomach cancer	3.66e-05	0.000349	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CKB—stomach cancer	3.64e-05	0.000347	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CA1—stomach cancer	3.64e-05	0.000347	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—FBP1—stomach cancer	3.64e-05	0.000347	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NDUFA2—stomach cancer	3.64e-05	0.000347	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—SERPINE1—stomach cancer	3.58e-05	0.000341	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL6—stomach cancer	3.55e-05	0.000339	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALDOB—stomach cancer	3.5e-05	0.000334	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL6—stomach cancer	3.47e-05	0.000331	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—RHOA—stomach cancer	3.45e-05	0.000329	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PLIN2—stomach cancer	3.42e-05	0.000326	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	3.42e-05	0.000326	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PDHA1—stomach cancer	3.41e-05	0.000325	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ECHS1—stomach cancer	3.41e-05	0.000325	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CA2—stomach cancer	3.33e-05	0.000317	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ALDOB—stomach cancer	3.32e-05	0.000316	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.3e-05	0.000315	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.29e-05	0.000314	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALOX5—stomach cancer	3.25e-05	0.00031	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RPL15—stomach cancer	3.25e-05	0.00031	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NT5E—stomach cancer	3.24e-05	0.000309	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PGAM1—stomach cancer	3.24e-05	0.000309	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	3.23e-05	0.000308	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—FADS1—stomach cancer	3.2e-05	0.000305	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—TYMP—stomach cancer	3.2e-05	0.000305	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—DPYD—stomach cancer	3.2e-05	0.000305	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NPM1—stomach cancer	3.19e-05	0.000304	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PPP2R1A—stomach cancer	3.17e-05	0.000302	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	3.14e-05	0.0003	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALDH7A1—stomach cancer	3.09e-05	0.000295	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PLCE1—stomach cancer	3.09e-05	0.000295	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RBP4—stomach cancer	3.08e-05	0.000294	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	3.08e-05	0.000293	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	3.07e-05	0.000293	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RPS26—stomach cancer	3.03e-05	0.000289	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PPIA—stomach cancer	3.01e-05	0.000287	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SREBF2—stomach cancer	3e-05	0.000286	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—UMPS—stomach cancer	2.97e-05	0.000283	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—RORA—stomach cancer	2.96e-05	0.000283	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.93e-05	0.000279	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.9e-05	0.000277	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.9e-05	0.000277	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTT1—stomach cancer	2.83e-05	0.00027	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CYP2A6—stomach cancer	2.8e-05	0.000267	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—FYN—stomach cancer	2.79e-05	0.000266	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALDOB—stomach cancer	2.78e-05	0.000265	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PDHA1—stomach cancer	2.76e-05	0.000263	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ECHS1—stomach cancer	2.76e-05	0.000263	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—AKR1C3—stomach cancer	2.72e-05	0.000259	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	2.67e-05	0.000254	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.65e-05	0.000253	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ENO1—stomach cancer	2.65e-05	0.000253	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.62e-05	0.00025	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.61e-05	0.000249	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.61e-05	0.000249	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—TYMP—stomach cancer	2.59e-05	0.000247	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—FADS1—stomach cancer	2.59e-05	0.000247	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALOX5—stomach cancer	2.58e-05	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	2.58e-05	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RPS19—stomach cancer	2.58e-05	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—AKR1C3—stomach cancer	2.58e-05	0.000246	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—DPYD—stomach cancer	2.54e-05	0.000242	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ENO1—stomach cancer	2.51e-05	0.00024	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	2.46e-05	0.000235	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SREBF2—stomach cancer	2.43e-05	0.000231	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—RORA—stomach cancer	2.4e-05	0.000229	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PLAU—stomach cancer	2.38e-05	0.000227	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CD44—stomach cancer	2.35e-05	0.000224	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—CAV1—stomach cancer	2.33e-05	0.000222	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	2.33e-05	0.000222	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—APOA1—stomach cancer	2.32e-05	0.000221	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.3e-05	0.00022	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.28e-05	0.000218	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RPS6—stomach cancer	2.28e-05	0.000217	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALDOB—stomach cancer	2.25e-05	0.000214	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTT1—stomach cancer	2.25e-05	0.000214	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CD44—stomach cancer	2.23e-05	0.000213	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CYP2A6—stomach cancer	2.22e-05	0.000212	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PRKCB—stomach cancer	2.22e-05	0.000211	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	2.21e-05	0.000211	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—AKR1C3—stomach cancer	2.16e-05	0.000206	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.12e-05	0.000202	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.11e-05	0.000202	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ENO1—stomach cancer	2.1e-05	0.000201	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HBEGF—stomach cancer	2.1e-05	0.0002	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ALOX5—stomach cancer	2.09e-05	0.000199	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.07e-05	0.000197	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—DPYD—stomach cancer	2.06e-05	0.000196	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	2.01e-05	0.000192	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPP2R1A—stomach cancer	2e-05	0.000191	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTP1—stomach cancer	1.96e-05	0.000187	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—HMOX1—stomach cancer	1.93e-05	0.000184	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	1.92e-05	0.000183	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PPP2R1A—stomach cancer	1.9e-05	0.000181	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CD44—stomach cancer	1.87e-05	0.000178	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.86e-05	0.000178	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—SERPINE1—stomach cancer	1.84e-05	0.000176	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—TYMS—stomach cancer	1.82e-05	0.000174	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTT1—stomach cancer	1.82e-05	0.000173	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GSTM1—stomach cancer	1.8e-05	0.000172	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CYP2A6—stomach cancer	1.8e-05	0.000171	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—RHOA—stomach cancer	1.78e-05	0.00017	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SMAD4—stomach cancer	1.76e-05	0.000168	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS3—stomach cancer	1.76e-05	0.000168	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—AKR1C3—stomach cancer	1.75e-05	0.000167	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ENO1—stomach cancer	1.7e-05	0.000162	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ERCC2—stomach cancer	1.69e-05	0.000162	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FYN—stomach cancer	1.67e-05	0.000159	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERCC2—stomach cancer	1.61e-05	0.000153	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—MTHFR—stomach cancer	1.59e-05	0.000152	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPP2R1A—stomach cancer	1.59e-05	0.000151	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—FGFR2—stomach cancer	1.57e-05	0.00015	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTP1—stomach cancer	1.56e-05	0.000148	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—HMOX1—stomach cancer	1.54e-05	0.000146	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CD44—stomach cancer	1.51e-05	0.000144	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MTHFR—stomach cancer	1.51e-05	0.000144	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—CAV1—stomach cancer	1.47e-05	0.00014	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—APOA1—stomach cancer	1.47e-05	0.00014	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.47e-05	0.00014	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—TYMS—stomach cancer	1.45e-05	0.000138	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IRS2—stomach cancer	1.44e-05	0.000137	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GSTM1—stomach cancer	1.43e-05	0.000136	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.4e-05	0.000134	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CAV1—stomach cancer	1.39e-05	0.000133	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APOA1—stomach cancer	1.39e-05	0.000133	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ERCC2—stomach cancer	1.35e-05	0.000128	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6ST—stomach cancer	1.32e-05	0.000126	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PPARG—stomach cancer	1.29e-05	0.000123	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPP2R1A—stomach cancer	1.28e-05	0.000122	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—APC—stomach cancer	1.27e-05	0.000121	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—VEGFA—stomach cancer	1.27e-05	0.000121	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—MTHFR—stomach cancer	1.26e-05	0.000121	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTP1—stomach cancer	1.26e-05	0.00012	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—HMOX1—stomach cancer	1.24e-05	0.000118	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MAPK3—stomach cancer	1.2e-05	0.000114	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6R—stomach cancer	1.18e-05	0.000112	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—TYMS—stomach cancer	1.17e-05	0.000112	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—CAV1—stomach cancer	1.17e-05	0.000111	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—APOA1—stomach cancer	1.16e-05	0.000111	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—ALB—stomach cancer	1.16e-05	0.000111	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GSTM1—stomach cancer	1.16e-05	0.00011	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—MAPK1—stomach cancer	1.14e-05	0.000109	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.11e-05	0.000106	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—NOS3—stomach cancer	1.11e-05	0.000106	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SERPINE1—stomach cancer	1.1e-05	0.000105	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—ERCC2—stomach cancer	1.09e-05	0.000104	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—KRAS—stomach cancer	1.08e-05	0.000103	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RHOA—stomach cancer	1.06e-05	0.000101	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS3—stomach cancer	1.05e-05	0.0001	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PPARG—stomach cancer	1.03e-05	9.78e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—MTHFR—stomach cancer	1.02e-05	9.76e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—stomach cancer	1.02e-05	9.69e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—PIK3CA—stomach cancer	9.9e-06	9.44e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERBB2—stomach cancer	9.85e-06	9.39e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TP53—stomach cancer	9.58e-06	9.14e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—CAV1—stomach cancer	9.44e-06	9e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—APOA1—stomach cancer	9.42e-06	8.98e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—ALB—stomach cancer	9.22e-06	8.79e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—HRAS—stomach cancer	9.16e-06	8.74e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDKN1B—stomach cancer	9.12e-06	8.7e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.02e-06	8.6e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—NOS3—stomach cancer	8.82e-06	8.41e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—CDKN1A—stomach cancer	8.42e-06	8.03e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PPARG—stomach cancer	8.3e-06	7.91e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—STAT3—stomach cancer	7.51e-06	7.16e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MAPK3—stomach cancer	7.18e-06	6.84e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—NOS3—stomach cancer	7.14e-06	6.8e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MYC—stomach cancer	6.98e-06	6.66e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—MAPK1—stomach cancer	6.83e-06	6.51e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EGFR—stomach cancer	6.83e-06	6.51e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—stomach cancer	6.53e-06	6.22e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—KRAS—stomach cancer	6.45e-06	6.15e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PIK3CA—stomach cancer	6.25e-06	5.96e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—PIK3CA—stomach cancer	5.93e-06	5.65e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HRAS—stomach cancer	5.48e-06	5.23e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—stomach cancer	5.25e-06	5e-05	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—PIK3CA—stomach cancer	4.96e-06	4.73e-05	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PIK3CA—stomach cancer	4.02e-06	3.83e-05	CbGpPWpGaD
